Holen Sie sich die Stockscreener-App
0.756
27.12%
0.1613
Vorhandelsmarkt:
.72
-0.036
-4.76%
Nexgel Inc Aktie (NXGL) Neueste Nachrichten
NEXGEL Reschedules Shareholder Update Call to April 23 - National Today
NEXGEL drops prior Celularity financing plan, sets April 23 update - Stock Titan
NEXGEL reschedules shareholder call, revises financing plan - MSN
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart.com
NEXGEL Reschedules Shareholder Call, Revises Financing Plan - MyChesCo
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
Pharma News: Should you avoid NEXGEL Inc stock right now2026 EndofYear Setup & Verified Swing Trading Watchlists - baoquankhu1.vn
Momentum Shift: Is NEXGEL Inc Equity Warrant benefiting from innovation trends2026 Sector Review & Momentum Based Trading Signals - baoquankhu1.vn
2 High-Flying Stocks with Exciting Potential and 1 We Ignore - Barchart.com
NexGel Inc stock (US65340W1027): Is its hydrogel innovation strong enough to drive U.S. medical grow - AD HOC NEWS
AUDUSD Update: Breaking Higher Following Completion of Corrective Structure - Barchart.com
AI Stocks: Will NEXGEL Inc benefit from rising consumer demandMarket Growth Review & Daily Price Action Insights - baoquankhu1.vn
TEST TEST TEST - Barchart.com
Sectors Review: Is NEXGEL Inc stock a good pick for beginners2026 Setups & Daily Technical Forecast Reports - baoquankhu1.vn
Analyst Calls: Should you avoid NEXGEL Inc stock right now2026 Trade Ideas & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... By GuruFocus - Investing.com Canada
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction - Bitget
NEXGEL drops prior financing plan, pushes Celularity update to April 15 - Stock Titan
3 Reasons to Avoid AIT and 1 Stock to Buy Instead - Barchart.com
3 Reasons to Avoid INGR and 1 Stock to Buy Instead - Barchart.com
NexGel Inc stock: Acquisition Deal to Triple Revenue Sparks Investor Interest - AD HOC NEWS
NVR's Quarterly Earnings Preview: What You Need to Know - Barchart
Sentiment Watch: Is NEXGEL Inc attractive for institutional investors2026 Short Interest & Safe Entry Momentum Tips - baoquankhu1.vn
Nexgel earnings missed by $0.09, revenue fell short of estimates - Investing.com Canada
Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN
3 Reasons to Sell RMAX and 1 Stock to Buy Instead - Barchart.com
Fed Watch: Is NEXGEL Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Shootin' the Bull about "has to" - barchart.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nexgel Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Published on: 2026-04-01 05:28:13 - baoquankhu1.vn
NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative
NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - TradingView — Track All Markets
Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - TradingView — Track All Markets
NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NXGL PE Ratio & Valuation, Is NXGL Overvalued - Intellectia AI
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - MarketScreener
NEXGEL delays earnings call a week to add detail on Celularity deal - stocktitan.net
Stocks in play: Quarterhill Inc. - Barchart.com
Earnings To Watch: Cal-Maine (CALM) Reports Q1 Results Tomorrow - Barchart.com
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders With an Update on Its Previously Announced Transaction With Celularity - 富途牛牛
Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
The Metals Company: Unlocking a Klondike-Quality Mineral Rush - Barchart
NEXGEL, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn
Johanna Gonzalez Announces TRUE 4G Method - Barchart.com
Published on: 2026-03-28 04:45:25 - baoquankhu1.vn
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - AD HOC NEWS
3 Stocks Under $50 That Concern Us - Barchart.com
2 Reasons to Watch BOOT and 1 to Stay Cautious - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
Oxford Industries Earnings: What To Look For From OXM - Barchart
0.06%
1.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):